SEC Form 4 · accession 0001179110-17-008661
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Xiaodong Wang
Director
Period of report
Jun 2, 2017
Accepted (ET)
Jun 6, 2017 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1 | Jun 2, 2017 | S | 5,539 | $40.00 | D | 55,000 | D | |
| Ordinary shares | May 11, 2017 | G | 19,682 | $0.00 | D | 12,505,711 | D | |
| Ordinary SharesF5 | May 11, 2017 | G | 9,841 | $0.00 | A | 224,372 | I | See Footnote 5 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each American Depositary Share represents 13 Ordinary Shares.
- F2The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F3This transaction involved a gift of securities by the Reporting Person to his children, one of whom shares Reporting Person's household. The Reporting Person disclaims beneficial ownership of the shares held by his minor child.
- F4This transaction involved a gift of securities by the Reporting Person to his minor child. The Reporting Person disclaims beneficial ownership of the shares held by his minor child.
- F5These securities are held in a UTMA account for Reporting Person's minor child, for which Reporting Person disclaims beneficial ownership.